https://www.selleckchem.com/products/cadd522.html
https://www.selleckchem.com/products/cadd522.html
Elements influencing long-term final results in relapsing-remitting multiple sclerosis: PRISMS-15. der the current sample size. • TwHF should be considered for the treatment of osteoarticular lesions in SAPHO syndrome in clinical practice because of significant efficacy, reliable safety, and high socioeconomic value. ChiCTR1900025912 Key points • This is the first clinical trial to evaluate Tripterygium wilfordii Hook F. (TwHF) in the treatment of synovitis, acne, pustulosis, hyper